Article Details
Retrieved on: 2018-04-14 20:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Two Sigma Investments</b> LP acquired a new position in shares of Fate Therapeutics (NASDAQ:FATE) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 170,636 shares of the biopharmaceutical company's stock, valued at approximately ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here